Emerging Companies Trailblazers

Disruption is driving tremendous change in virtually every industry in the modern economy. With our legal guidance, hundreds of game-changing companies have successfully entered the marketplace, creating new products and services to challenge their field and improve how things are done. Matching your creativity, we have developed techniques to efficiently and effectively serve the unique needs of an emerging business.


Soup To Nuts  

We assist clients throughout the business lifecycle, from the initial protection of ideas to IPO and beyond. We believe our focus on client service is the foundation of our collective success. As a Kilpatrick Townsend client, we will provide your emerging company with unsurpassed legal representation spanning all of your critical needs. Our attorneys frequently serve as virtual outside general counsel to rapidly-growing companies, providing advice to boards of directors and senior management on corporate governance, joint ventures, and strategic transactions — bringing life to new businesses


  • Corporate Formation, including stand-alone and U.S.-based foreign subsidiary corporations
  • Financing Transactions, including convertible debt, SAFE agreements, and preferred stock financing transactions
  • Business Transactions, including outsourcing, licensing and joint development agreements, and privacy and information security
  • Strategic Transactions, including asset and stock sales, mergers and acquisitions, spinoffs, divestitures, and rollups
  • Tax, including international and domestic tax counseling and dispute resolution
  • Employment Benefits/Labor & Employment, including equity compensation, benefits, and employment matters (e.g., executive retention plans, reductions in force, and   employment litigation)
  • Intellectual Property, including patent prosecution, trademark and brand counseling, and enforcement
  • Litigation, including internal investigations, government and regulatory enforcement matters, complex business and intellectual property litigation, appellate litigation, and alternative dispute resolution


A Strong Start

Through our unique Kickstart program, we address challenges faced by startups and provide the solid footing needed to raise capital, attract and keep the best talent, protect assets, and maintain strong partnerships and supply chains. Our collaborative approach and unparalleled access allow us to give specialized, comprehensive advice to first-time and serial entrepreneurs, who want to rapidly scale new businesses by accessing private investment from high-net-worth individuals and venture capital firms. As such, we have successfully advanced hundreds of emerging companies, using pragmatic, tailored, and cost-effective solutions on a variety of matters, including:

  • Choice of entity
  • Founders Share Issuances & Restrictions
  • Stock Option Plans & Other Forms of Equity-Based Compensation
  • Debt & Equity Financing Agreements
  • Board Governance & Composition
  • Licensing & Commercial Transactions
  • Privacy & Information Security
  • Exits by Acquisition or Initial Public Offering
Related Services


Represented Deciduous Therapeutics, Inc. in connection with a $6.5 million Series Seed financing.

Represented Immutics, Inc. in connection with a $40 million Series B financing.

Represented Aethan Capital in connection with $25 million investment.

Represented Boost Biomes in connection with $4 million convertible note financing.

Represented a biotech startup in connection with an $11 million Series A financing by Khosla Ventures.

Represented Yonghua Capital in connection with:

  • a $60 million Series C financing for Hyperfine Research, Inc.
  • a $32 million Series C financing for GenomeDx, Inc.
  • a $25 million Series B financing for Taris Medical/Taris Holdings.
  • a $14 million Series B financing for Ultivue.

Represented a biotech startup in connection with a $7 million Series Seed financing by Andresen Horowitz.

Represented TTTech in connection with investments in a Silicon Valley automotive start-up as well as joint ventures and related intellectual property transactions.

Represented NVOLVE, Inc., a medication adherence technology company, in connection with a Series Seed financing transaction led by Dioko Ventures.

Primary Contacts View All

If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”